Now on
Orphan Drug Designation to Sirolimus
The European Commission grants Orphan Drug Designation to Sirolimus (Rapamycin) for the treatment of beta thalassaemia intermedia and major
Agreement between Rare Partners and Fondazione Telethon
Agreement between Rare Partners and Fondazione Telethon
#runandimagetofly with Alessandro and his fundraising campaign for Rare Partners
#runandimagetofly with Alessandro and his fundraising campaign for Rare Partners.
Class October, 2014. An article on Alessandro, one of the protagonists of Rare Partners' fundraising campaign at the 2014 Milan City Marathon.
Collaboration agreement between Telethon Foundation and Rare Partners
Collaboration agreement between Telethon Foundation and Rare Partners
The European Commission grants Orphan Drug Designation to 4,6,4’–trimethylangelicin for the treatment of Cystic Fibrosis
The European Commission grants Orphan Drug Designation to 4,6,4’–trimethylangelicin for the treatment of Cystic Fibrosis